Albany, NY -- (SBWIRE) -- 05/23/2017 -- Global Medical Microbiology Testing Technologies Market: Overview
This report provides forecast and analysis of the medical microbiology testing technologies market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on medical microbiology testing technologies globally. It includes drivers and restraints of the medical microbiology testing technologies market and their impact on each region during the forecast period. The report also comprises the study of current issue and opportunities for medical microbiology testing manufacturers.
In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players. The dashboard provides detailed comparison of medical microbiology testing manufacturers on parameters such as operating margin, unique selling propositions, collective market share, and geographic concentration. The study encompasses market attractiveness analysis, by indication, type, technology type, application type, end user type and region.
Global Medical Microbiology Testing Technologies Market: Segmentation
The report includes usage of Medical Microbiology Testing Technologies and the revenue generated from sales of medical microbiology testing technologies in all regions and important countries in these regions. By indication, the global medical microbiology testing technologies market has been segmented into respiratory diseases, neurological diseases, infectious diseases and others. By technology, the market is segmented into Cell Culture, Microscopy and Serology. On the basis of application, the market is segmented into Diagnostic and Treatment Monitoring. On the basis of end user, the market is segmented into Hospital Labs, Pathology Labs, Research Institutes and others.
Market numbers have been estimated based on average consumption and weighted average pricing of medical microbiology testing technologies and the revenue is derived through regional pricing trends and the epidemiology of specific diseases. Market size and forecast for each segment have been provided in the context of global and regional markets. The Medical Microbiology Testing Technologies market has been analyzed based on expected demand. All key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of Medical Microbiology Testing Technologies in different regions. Top down approach has been used to estimate the Medical Microbiology Testing Technologies market by regions. Market numbers for indication, technology, application, and end user segments have been derived using the top-down approach, which is cumulative of each region's demand. Company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates.
This exhaustive report includes 30 data tables and 121 figures to give readers a 360° view of the Medical Microbiology Testing Technologies Market. Browse through this 210-page report to know what factors will shape the market during the period 2016-2024
http://www.transparencymarketresearch.com/microbiology-testing-technologies-market.html
Global Medical Microbiology Testing Technologies Market: Competitive Landscape
A number of primary and secondary sources were consulted during the course of the study. Secondary sources include FACTIVA, NCBI, Google Books, company websites, journals, press releases, Morningstar, Hoover's, and company annual reports and publications.
The report provides detailed competitive and company profiles of key participants operating in the global market. Key players in the global Medical Microbiology Testing Technologies market include Agilent Technologies Inc., Becton, Dickinson & Company, Beckman Coulter Inc. (A Danaher Company), Biomerieux SA, Bio-Rad Laboratories Inc., Roche Holding AG, among others.
The market has been segmented as below:
Global Medical Microbiology Testing Technologies Market – By Indication
Respiratory Diseases
Neurological Diseases
Infectious Diseases
Others
Global Medical Microbiology Testing Technologies Market – By Technology
Cell Culture
Microscopy
Serology
Global Medical Microbiology Testing Technologies Market – By Application
Diagnostic
Treatment Monitoring
Global Medical Microbiology Testing Technologies Market – By End User
Hospital Labs
Pathology Labs
Research Institutes
Others
Global Medical Microbiology Testing Technologies Market – By Region
North America
U.S.
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
New Zealand
Rest of Asia Pacific
Middle East and Africa (MEA)
Saudi Arabia
UAE
RSA
Rest of MEA
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Medical Microbiology Testing Technologies Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11603